Target intelligence / Profile preview

High mobility group nucleosome binding domain 1 pseudogene 33 (HMGN1P33)

Target
HMGN1P33
Molecular classification
Pseudogene
01

Overview

High mobility group nucleosome binding domain 1 pseudogene 33 (HMGN1P33) is a human pseudogene, meaning it is a DNA sequence similar to a functional gene (HMGN1) but generally considered non-functional due to disabling mutations that prevent it from encoding a full-length, functional protein. Like other pseudogenes, HMGN1P33 may be transcribed into RNA, but there is currently no experimental evidence that it produces a protein or has a direct biological function. Some pseudogenes are known to have regulatory functions at the RNA level, such as acting as microRNA sponges or generating small interfering RNAs, but there is no data supporting such roles for HMGN1P33 specifically. It is not considered a receptor, enzyme, or classic drug target, nor is it linked to specific biomarkers, mechanisms of action, or safety concerns in therapeutics.

Other names
HMGN1P33high mobility group nucleosome binding domain 1 pseudogene 33
02

Biological functions

Possible roles as non-coding RNA (general to pseudogenes, not specifically proven for HMGN1P33)May participate in gene regulation via RNA interference or as miRNA decoy (speculative, based on general pseudogene biology, not confirmed for HMGN1P33 specifically)
03

Disease associations

No direct disease associations specific to HMGN1P33 have been reportedPseudogenes broadly may contribute to disease regulation or cancer progression (no evidence for this specific pseudogene)

Beyond the preview

Go deeper on High mobility group nucleosome binding domain 1 pseudogene 33 (HMGN1P33).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group nucleosome binding domain 1 pseudogene 33 (HMGN1P33).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call